We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Formerly part of M18, technical guidance for industrial plant operators (and their contractors) who monitor effluent discharges to water and sewer.
How to check that a laboratory is allowed to buy ozone-depleting substances (ODS).
Get help to classify organic chemicals that contain certain permitted additives or can be dissolved in water, for import and export.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Customer declaration of specific uses of the scheduled category 1 or 2 substances (individual transactions).
Offending behaviour programmes and interventions currently available for offenders in England and Wales.
Guidance on the European Union regulation on explosives precursors, including licensing, labelling and reporting suspicious activity
Guidance on a strategy for genotoxicity testing and mutagenic hazard assessment of impurities in chemical substances.
Guidance for prescribing vets on the use of the cascade.
Requirements if you work with ozone-depleting substances (ODS).
Details of the process changes for established medicines, effective from 1 March 2024, which apply specifically to chemical products.
Customer declaration of specific uses of the scheduled category 1 or 2 substances (multiple transactions).
The National Treatment Agency for Substance Misuse (NTA) was established in 2001 to improve the availability, capacity and effectiveness of drug treatment. It became part of Public Health England in 2013.
The MHRA is part of the Access Consortium along with the Therapeutic Goods Administration, Health Canada, Health Sciences Authority of Singapore and Swissmedic.
How to identify and classify waste that contains POPs.
Guidance on the planning for mineral extraction in plan making and the application process.
How companies or individuals based in Great Britain should share data and information on the same chemical substance and jointly submit that information to the ‘Comply with UK REACH’ service.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).